about
Serotonin syndrome: a brief reviewA patient with encephalitis associated with NMDA receptor antibodiesA comparison of the pharmacokinetics of oral and sublingual cyproheptadineNeuroleptic malignant syndrome induced by atypical antipsychotics.Neuroleptic malignant syndrome caused by a combination of carbamazepine and amitriptyline.Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicityOlanzapine-Induced Malignant Neuroleptic SyndromeOverlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital ANeuroleptic malignant syndrome: an easily overlooked neurologic emergency.Serotonin toxicity: a short review of the literature and two case reports involving citalopram.Rediscovering catatonia: the biography of a treatable syndrome.An approach to iatrogenic deaths.Brain-heart interactions: physiology and clinical implications.Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine.Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure.Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports.Serotonin syndrome with elevated paroxetine concentrations.Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.The toxicology and comorbidities of fatal cases involving quetiapine.
P2860
Q24678431-7D8F4856-4DC0-4A8C-8B2E-861F3B6C85A2Q27480951-AAE56213-FF70-40EA-9A09-C854258077CCQ28256415-E2832661-5FE2-41C7-B323-C9CEF6A3C15AQ35194436-81EB9556-9F79-4FCF-814B-78494AD55ED1Q36168696-99855C44-267F-46D7-9148-38322A500935Q36465395-BCFC508E-04A7-4909-959A-2E87818996F5Q36972060-BF9BBCE3-BBDF-4229-B78C-25A721809C57Q37084224-1993DD59-AD9C-480A-8A36-7DE5348DE394Q37596135-8AA805C5-7D1D-4473-BDED-AD9E29F946DCQ37864955-2322A2F3-0412-48F3-BD62-BF8782602C2CQ38065228-8ED0FC5D-605B-4A2C-86B5-F69D31D3DCB4Q38714784-BCF62708-D08C-4AA2-BF5A-AEF72834A04DQ38798203-A9978037-57BB-41DB-8137-C013DDB0B65BQ40475813-59A3D552-FBB4-4F8F-BFD6-F49F90CE5EFBQ40484332-03ADCDD5-A3F5-4983-94FC-F6B7E6E1EC9AQ42283313-AF7B3FD0-1339-44F9-8C2C-38AD8AE78A62Q44202388-14FA0AA0-0E35-44B3-A8A9-B80BA269B9DBQ44741596-3DD265FF-9FC0-4636-868E-8A0B699421E0Q45054821-8C78B512-007A-4AAF-99A4-730AFFC93783Q46114930-6F840E06-F0DF-4DF6-8D0C-2A02DBC16818
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The neuroleptic malignant and serotonin syndromes.
@ast
The neuroleptic malignant and serotonin syndromes.
@en
type
label
The neuroleptic malignant and serotonin syndromes.
@ast
The neuroleptic malignant and serotonin syndromes.
@en
prefLabel
The neuroleptic malignant and serotonin syndromes.
@ast
The neuroleptic malignant and serotonin syndromes.
@en
P1476
The neuroleptic malignant and serotonin syndromes.
@en
P2093
Carbone JR
P304
P356
10.1016/S0733-8627(05)70127-9
P577
2000-05-01T00:00:00Z